Cargando…
Characterization of SOX2, OCT4 and NANOG in Ovarian Cancer Tumor-Initiating Cells
SIMPLE SUMMARY: SOX2, OCT4, and NANOG are enriched in ovarian cancer spheroids and correlate with tumor-initiating cell markers, CD117 and ALDH/CD133. SOX2, relative to OCT4 or NANOG, is a stronger indictor of chemoresistance, tumor-initiation, and recurrent disease. Including SOX2 in evaluation of...
Autores principales: | Robinson, Mikella, Gilbert, Samuel F., Waters, Jennifer A., Lujano-Olazaba, Omar, Lara, Jacqueline, Alexander, Logan J., Green, Samuel E., Burkeen, Gregory A., Patrus, Omid, Sarwar, Zinia, Holmberg, Ryne, Wang, Christine, House, Carrie D. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7828139/ https://www.ncbi.nlm.nih.gov/pubmed/33445692 http://dx.doi.org/10.3390/cancers13020262 |
Ejemplares similares
-
TWEAK–Fn14–RelB Signaling Cascade Promotes Stem Cell–like Features that Contribute to Post-Chemotherapy Ovarian Cancer Relapse
por: Holmberg, Ryne, et al.
Publicado: (2023) -
Immunoexpression of stem cell markers SOX-2, NANOG AND OCT4 in ameloblastoma
por: Martins Balbinot, Karolyny, et al.
Publicado: (2023) -
SUMOylation Represses Nanog Expression via Modulating Transcription Factors Oct4 and Sox2
por: Wu, Yongyan, et al.
Publicado: (2012) -
SOX2, OCT4 and NANOG: The core embryonic stem cell pluripotency regulators in oral carcinogenesis
por: Swain, Niharika, et al.
Publicado: (2020) -
Prognostic Significance of the Pluripotency Factors NANOG, SOX2, and OCT4 in Head and Neck Squamous Cell Carcinomas
por: Pedregal-Mallo, Daniel, et al.
Publicado: (2020)